跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
劉 志中
助理教授
,
麻醉學科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北神經醫學中心
https://orcid.org/0000-0001-7354-2095
電子郵件
aneslcc
gmail
com
h-index
282
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2025
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(30)
資料集
(6)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Chung Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Odds Ratio
100%
Retrospective Cohort Study
82%
Diabetes
76%
Apoplexy
67%
Osteoarthritis
62%
Anterior Cruciate Ligament
60%
Adverse Outcome
51%
Low Back Pain
51%
Neuropathic Pain
51%
Surgical Mortality
41%
Septicemia
39%
Cartilage Degeneration
37%
Injection
36%
Glutamic Acid
35%
Quality Improvement
34%
Meniscectomy
34%
Joint Injection
34%
Knee
33%
Cystine
32%
Antiporter
32%
Surgeon
32%
General Anesthesia
32%
Cohort Analysis
32%
Hazard Ratio
31%
Patient with Diabetes
31%
Chronic Kidney Disease
30%
Major Surgery
30%
Restylane
29%
Comorbidity
29%
Adverse Event
26%
Infectious Complication
26%
Anesthesiology
25%
Medical Event
25%
Noncardiac Surgery
25%
Systematic Review
25%
Meta-Analysis
25%
Renal Failure
25%
Neuraxial Anesthesia
25%
Catheter Thrombosis
25%
CHA2DS2-VASc Score
25%
Heart Disease
25%
Ogilvie Syndrome
25%
Hip Fracture
25%
Foot Malformation
25%
Herniorrhaphy
25%
Medical Care
25%
Thrombosis
25%
Urosepsis
25%
Parkinsonism
25%
Observational Study
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
77%
Neuropathic Pain
51%
Cerebrovascular Accident
43%
Osteoarthritis
36%
Cartilage Degeneration
34%
End Stage Renal Disease
25%
Non-Steroidal Anti-Inflammatory Drug
25%
Temozolomide
25%
Honokiol
25%
Chronic Kidney Failure
25%
Infectious Complication
25%
Sulfasalazine
25%
Glioma
25%
Maturity Onset Diabetes of the Young
25%
Cystine
25%
Catheter Thrombosis
25%
Glutamic Acid
25%
Cardiovascular Disease
25%
Chronic Obstructive Lung Disease
25%
Antiporter
25%
Rat
24%
Surgical Mortality
17%
N-Acetylcysteine
11%
Pneumonia
10%
Potassium Ion
8%
Septicemia
8%
Postoperative Complication
8%
Hospital Mortality
8%
Cellulitis
8%
Hemoglobins
8%
Wistar Rat
8%
Synovitis
8%
Diabetic Neuropathy
7%
Paresthesia
7%
Defined Daily Dose
6%
Gabapentin
5%
Side Effect
5%
Disease Exacerbation
5%
Nursing and Health Professions
Confidence Interval
69%
Odds Ratio
60%
Cohort Analysis
58%
Cerebrovascular Accident
34%
Septicemia
32%
CHA2DS2-VASc Score
25%
Herniorrhaphy
25%
Major Surgery
25%
Hypothermia
25%
Patient with Diabetes
25%
Systematic Review
25%
Cesarean Section
25%
Adverse Outcome
25%
Low Back Pain
25%
Network Meta-Analysis
25%
Clinical Trial
25%
Chronic Kidney Failure
25%
Postoperative Complication
15%
Infectious Complication
15%
National Health Insurance
12%
Atrial Fibrillation
12%
Hospital Mortality
12%
Surgical Mortality
11%
Adverse Event
10%
Perioperative
9%
Antiporter
7%
Propensity Score
6%
Cellulitis
6%
Intensive Care
6%
Heart Atrium Thrombosis
6%
Pneumonia
6%
Epidural Anesthesia
5%
Spinal Anaesthesia
5%
